GJB2 and deafness: The identification of the GJB2 gene revolutionized the clinical approach to hearing loss, particularly for “isolated” deafness, which constituted the majority of cases labeled as “deafness of unknown cause.” Next-generation sequencing technologies have significantly improved the diagnostic rate for genetic hearing loss, allowing the detection of novel variants in known deafness-related genes and the identification of new genes associated with hearing disease.